Repare Therapeutics Inc.

NASDAQ:RPTX

1.32 (USD) • At close December 20, 2024
Bedrijfsnaam Repare Therapeutics Inc.
Symbool RPTX
Munteenheid USD
Prijs 1.32
Beurswaarde 56,114,124
Dividendpercentage 0%
52-weken bereik 1.225 - 8.49
Industrie Biotechnology
Sector Healthcare
CEO Mr. Lloyd Mitchell Segal
Website https://www.reparerx.com

An error occurred while fetching data.

Over Repare Therapeutics Inc.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including

Vergelijkbare Aandelen

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.56 USD

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

3.57 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

41.49 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

2.49 USD

RxSight, Inc. logo

RxSight, Inc.

RXST

33.66 USD

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

17.4 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)